Embryonal Brain Tumors Beyond Medulloblastoma and ATRT

Status: draft · Last updated 2026-11-13 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • "CNS-PNET" no longer exists :
    • Get methylation profiling on any poorly differentiated pediatric tumor.
    • In ACNS0332, 71% of nonpineal "PNETs" were other tumors, mostly HGG .
  • ETMR:
    • Molecular: C19MC amplification or DICER1 (often germline); LIN28A-positive.
    • Patients: infants.
    • Outcome: 5-year OS under 30%, and brainstem cases are uniformly fatal.
    • Best results: GTR plus intensive chemotherapy, with HDCT or IRS-III .
  • CNS NB-FOXR2:
    • Imaging: supratentorial, large, cystic and calcified, little edema.
    • Outcome: 5-year OS about 85% with CSI plus chemotherapy .
  • BCOR ITD:
    • Patients and sites: young children; hemispheric or cerebellar.
    • Outcome: chemotherapy alone fails, so radiation matters .
  • Pineoblastoma is now a pineal tumor. CIC sarcoma is mesenchymal .

"CNS-PNET" was a histologic wastebasket for poorly differentiated small-round-blue-cell tumors.

Medulloblastoma and ATRT have their own topics. Pineoblastoma is now a pineal tumor and is covered in pineal region tumors.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:embryonal_tumors:5991de446e072bed© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Former supratentorial CNS-PNET redistributed into ETMR, CNS neuroblastoma FOXR2-activated, CNS tumor with BCOR internal tandem duplication, CNS embryonal tumor NEC/NOS and non-embryonal look-alikes; DNA methylation profiling is required for diagnosisTHE BREAKUP OF "CNS-PNET"Supratentorial"CNS-PNET"(histology,pre-2016)ETMRC19MC amplification or DICER1; LIN28A+infants (median ~3 y); supratentorial orbrainstem / cerebellum; 5-yr OS <30%CNS neuroblastoma, FOXR2-activatedsupratentorial, large, cystic / calcified,little edema; 5-yr OS ~85%CNS tumor with BCOR ITDyoung children; cerebral or cerebellarhemisphere; well circumscribedCNS embryonal tumor, NEC / NOSno specific molecular group"Look-alikes" (not embryonal)HGG, ATRT, ependymoma, CIC sarcomae.g., 71% of nonpineal "PNETs" in ACNS0332were other entities, mostly HGGDNA methylation profiling is required for diagnosisthumbnails: schematic midsagittal child brain, typical site highlighted; not to scale
The breakup of supratentorial "CNS-PNET". Tumors once diagnosed as CNS-PNET on histology now resolve, by DNA methylation profiling, into ETMR (C19MC or DICER1), CNS neuroblastoma FOXR2-activated, CNS tumor with BCOR internal tandem duplication, CNS embryonal tumor NEC/NOS, and many non-embryonal look-alikes, mostly high-grade gliomas. Not to scale.

WHO 2021 embryonal tumors

How "CNS-PNET" dissolved

ETMR (embryonal tumor with multilayered rosettes)

CNS neuroblastoma, FOXR2-activated (CNS NB-FOXR2)

CNS tumor with BCOR internal tandem duplication

The look-alikes and NEC/NOS

Related topics

References

  1. Sturm D, Orr BA, Toprak UH, et al. New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164(5):1060–1072. doi:10.1016/j.cell.2016.01.015. PMID 26919435. verified
  2. Hwang EI, Kool M, Burger PC, et al. Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children's Oncology Group randomized ACNS0332 trial. J Clin Oncol 2018;36(34):JCO2017764720. doi:10.1200/JCO.2017.76.4720. PMID 30332335. verified
  3. von Hoff K, Haberler C, Schmitt-Hoffner F, et al. Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro Oncol 2021;23(9):1597–1611. doi:10.1093/neuonc/noab136. PMID 34077956. verified
  4. Liu APY, Dhanda SK, Lin T, et al. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol 2022;144(4):733–746. doi:10.1007/s00401-022-02484-7. PMID 35982322. verified
  5. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106. PMID 34185076. verified
  6. Juhnke BO, Gessi M, Gerber NU, et al. Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol 2022;24(1):127–137. doi:10.1093/neuonc/noab100. PMID 33908610. verified
  7. Lambo S, Gröbner SN, Rausch T, et al. The molecular landscape of ETMR at diagnosis and relapse. Nature 2019;576(7786):274–280. doi:10.1038/s41586-019-1815-x. PMID 31802000. verified
  8. Lambo S, von Hoff K, Korshunov A, Pfister SM, Kool M. ETMR: a tumor entity in its infancy. Acta Neuropathol 2020;140(3):249–266. doi:10.1007/s00401-020-02182-2. PMID 32601913. verified
  9. Hanson D, Hoffman LM, Nagabushan S, et al. A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes. Neurooncol Adv 2020;2(1):vdaa120. doi:10.1093/noajnl/vdaa120. PMID 33196040. verified
  10. Tietze A, Mankad K, Lequin MH, et al. Imaging characteristics of CNS neuroblastoma-FOXR2: a retrospective and multi-institutional description of 25 cases. AJNR Am J Neuroradiol 2022;43(10):1476–1480. doi:10.3174/ajnr.A7644. PMID 36137662. verified
  11. Ferris SP, Velazquez Vega J, Aboian M, et al. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathol 2020;30(1):46–62. doi:10.1111/bpa.12747. PMID 31104347. verified

Verification (2026-11-13):

Caveats: